Embryonic and fetal mortality reduce lambing rates and litter sizes, thus contributing to economic losses in the sheep industry. In the current study, the timing of late embryonic and fetal loss in ewes and the factors with which these losses were associated were examined. Ewes lambing and lambs born were compared with pregnancy diagnosis and counts of embryos by ultrasonography near d 25, 45, 65, or 85 of gestation. Approximately 19.9% of the ewes experienced late embryonic loss, fetal loss, or both; and 21.2% of the embryos or fetuses were lost from d 25 to term. Potential offspring were lost throughout gestation; 3.7% of embryos from d 25 to 45, 4.3% of fetuses from d 45 to 65, 3.3% from d 65 to 85, and 11.5% from d 85 to parturition; thus, approximately 3 to 4% of the potential offspring were lost for each 20-d period of pregnancy beyond d 25. A greater proportion of ewes lost one (36.7%) rather than all (20.5% single; 3.8% multiple) embryos or fetuses. The patterns of loss were similar in ewes mated during the anestrous season and the transitional period and did not vary with service period within breeding season or method of synchronization of estrus. Late embryonic or fetal losses were not related to the temperature-humidity index. Maternal serum collected near d 25, 45, 65, or 85 of gestation was assayed for concentrations of progesterone, estradiol-17beta , and vascular endothelial growth factor (VEGF). The proportions of embryos or fetuses lost were associated with breed type (P < 0.05), as were concentrations of progesterone (P < 0.01), estradiol (P < 0.05), and VEGF (P < 0.01). The relationships of loss or retention of pregnancy to hormonal variables at the 4 stages studied were limited. Complete and partial losses increased rapidly as maternal progesterone at d 25 decreased below 2 ng/mL (P < 0.05). Survival of fetuses within a litter from d 25 to 65 was greater for ewes with medium concentrations of VEGF near d 25 and from d 65 to parturition was greater for ewes with high concentrations of VEGF near d 45 (P < 0.05). In summary, late embryonic or fetal losses occurred from d 25 throughout gestation and varied with breed type and with concentrations of progesterone in maternal serum on d 25.
The development of ovarian follicular and luteal structures during the estrous cycle and early pregnancy in ewes was examined. Ewes were treated with prostaglandin F2 alpha to induce estrus; they were placed with either two fertile or two vasectomized rams and observed for estrus twice daily. Beginning at estrus (Day 0), ovaries were scanned for CL and for follicles > or = 2 mm by transrectal ultrasonography daily for the first 25 days of pregnancy (PREG, n = 17 ewes) or until Day 8 of the second estrous cycle (CYC, n = 15 ewes). Jugular blood samples were collected at ultrasonography and on Days 30, 35, and 40 of gestation for RIA of progesterone and estradiol-17 beta. Total follicles (17.6 +/- 1.3), number of follicles > or = 4 mm in diameter (11.3 +/- 0.6), and number of follicles that became the largest during the first 16 days of pregnancy or the first estrous cycle (4.9 +/- 0.3) did not differ between PREG and CYC ewes. Number of newly detected follicles each day and difference in mean diameter between the largest two follicles and all other follicles were similar between PREG and CYC ewes until luteal regression. At that time, difference in diameter between the largest two follicles and all other follicles increased in CYC ewes in parallel with estradiol-17 beta in serum. Mean concentrations of progesterone in serum were higher in PREG than in CYC ewes (2.4 +/- 0.1 vs. 2.0 +/- 0.1 ng/ml; p < 0.05) before onset of luteal regression, but mean areas of CL did not differ.(ABSTRACT TRUNCATED AT 250 WORDS)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.